Ultrasound Techniques

Ultrasound-guided Popliteal sciatic Block - Single Injection

Figure 1

The patient is the prone position. The premedication of an adult, average size patient typically consists of 2-4 mg of midazolam; 250mg -500mg of alfentanyl is administered just before insertion of the needle.

TIP: Make sure the foot on the side of the block is protruding off the table. This will allow for detection and accurate interpretation of the motor response of the foot and toes.

Figure 2

Equipment:

Ultrasound machine with 6-8 MHz probe

Nerve block tray with following equipment items:

  1. Betadine soaked sponges
  2. 4”x4” gauze packs
  3. Sterile gel for the ultrasound probe
  4. Local anesthetic (30-40ml)
  5. Insulated nerve stimulator needle (50 mm)
  6. Injection pressure monitor (optional)
  7. Sterile gloves
  8. Surface electrode (optional)
  9. Nerve stimulator (optional)
  10. Ruler and skin marker
  11. Remote controller (foot pedal) for the nerve stimulator (optional)
Figure 3

The landmarks for this block include:

  1. Popliteal crease
  2. Tendon of biceps femoris (laterally)
  3. Tendon of semitendinosus (medially)
Figure 4

The landmarks are labeled  with a marking pen.

Figure 5

Orient yourself as to which part of the probe corresponds to medial, lateral, superior and inferior part of the screen. After applying a large, sterile “Tegaderm” and sterile gel to the probe, touch the end of the probe with the finger and observe the position of the shadow that occurs with the touch.

TIP: Make sure that there is no air trapping between the “Tegaderm” and the probe. Any trapped air will results in “shadowing” due to the poor acoustic impedance of the air.

Figures 6-7

The ultrasound probe (6-8MHz) is applied above the popliteal crease and angled to visualize popliteal artery.

The popliteal artery (PA) is easily identified as a hollow, hypoechoic, pulsating viscus. When in doubt, a color Doppler mode can be used to demonstrate the blood flow. Pulse-wave Doppler (PWD; Figure 8) mode can also be used to distinguish between the pulsatile (arterial flow) and the laminar (venous) flow. Popliteal vein is typically slightly lateral and superficial to the artery. The vein is often missed on the exam as it collapses with minimal probe pressure. The nerve(s) is see superficial and lateral to the artery. The tibial (TN) and common peronneal (CPN) nerves are typically separated closer to the popliteal fossa crease and can be seen as two slightly hyperechoic, oval structures lateral to the popliteal artery. As the probe is moved closer to the popliteal fossa crease, the common peroneal nerve is usually lost in the view; tracking the tibial nerve proximally brings both divisions into the view until they eventually form a single nerve at 6-8 cm above the crease (Figures 9 & 10).

The same image as 6 without the nerve labels.
Figure 8

This image shows the typical pulsatile pattern when pulse wave Doppler (PWD) is used across the popliteal artery. Pulse wave Doppler can be most useful to discern between arterial and venous flow, particularly when image quality does not allow for color flow imaging of sufficient quality.

Figures 9-10

These images show the sciatic nerve in the popliteal fossa before its divergence into tibial (TN) and common peroneal (CPN) nerves. Figures 9 & 10 are identical and demonstrate the anatomy of the sciatic nerve approximately 7 cm above the fossa with and without labeling the nerve. The nerve (SN) is seen as a mutli-compartment, slightly hyperechoic structure superficial (approximately 2 cm bellow the skin) and slightly lateral to the popliteal artery (TN).

FIgure 9

Figure 10

Figure 11

The needle is connected to the nerve stimulator (1.0 mA; optional) and inserted at a steep angle to the long axis of the ultrasound probe (Figure 11) and its path is visualized usually by the shadowing and its effect on the neighboring structures.

Figure 12

Once the nerve is localized (using US or obtaining a motor response to nerve stimulation), local anesthetic is injected while paying attention to avoid excessive resistance (<20 psi).

Figure 13

The local anesthetic (LA) is shown layering around the sciatic nerve. Injections are best made lateral and medial to the artery to complete the spread of the local anesthetic. After the injection of local anesthetic, nerve stimulation can not be relied upon for any consecutive injections; reliance on the resistance to injection is the only protection against injection into a potentially anesthetized nerve.

TIP: If the resistance to injection exceeds 20 psi, maintain the syringe pressure to 20 psi and slightly rotate the needle. This almost always leads to dislodgment of the needle bevel from the low-compliant space the allows the injection <20 psi.

 

Site map

Acknowledgments



Valid XHTML 1.0!


COPYRIGHT © 1996, 2004 NYSORA.COM
No part of this web page may be reproduced without the permission of the authors.

DISCLAIMER: The material presented on this Web page has not been peer-reviewed. The indications, techniques and dosages on this Web page have been recommended in the medical literature and/or conform to OUR clinical practice. The medications and equipment have not necessarily been approved by the Food and Drug Administration (FDA) for use in the techniques and dosages for which they are recommended. The package insert for each drug and/or equipment should be consulted for use and dosage as recommended by the FDA. Because standards, practices and recommendations change, it is advisable to keep abreast of revised recommendations, particularly those concerning new drugs and techniques. While the techniques and dosages described are successfully used in our practice, they should be followed with a discretion since their complications may be dependent on the operator, patient and/or other accompanying clinical circumstances. The development and maintenance of this web page has not been supported by any pharmaceutical or medical manufacturing industry. The medications and/or equipment discussed in the web page is shown solely for teaching purposes. Similar equipment or medications from other manufacturers may produce similar clinical results to ours.